High content analysis of histone acetylation in human cells and tissues

Journal of Neuroscience Methods

Volumn 193, Issue 1, 2010, Pages 54-61

  Narayan, Pritika J ^a   Dragunow, Michael ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Epigenetic; HDAC inhibitors; High content analysis; Histone acetylation; SK N SH cells; Valproic acid

Indexed keywords

HISTONE H3; TRICHOSTATIN A; VALPROIC ACID;

ACETYLATION; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; AUTOMATION; CELL ASSAY; COMPUTER PROGRAM; CONCENTRATION RESPONSE; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING SYSTEM; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TIME; WESTERN BLOTTING;

ACETYLATION; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; BRAIN; CELL COUNT; CELL LINE, TUMOR; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; TIME FACTORS; VALPROIC ACID;

EID: 77957663117     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2010.08.032     Document Type: Article

References (48)

1. Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M., Finn P., et al. Quantitative proteomic analysis of post-translational modifications of human histones. Mol Cell Proteomics 2006, 5:1314-1325.
2. Benali A., Leefken I., Eysel U.T., Weiler E. A computerized image analysis system for quantitative analysis of cells in histological brain sections. J Neurosci Methods 2003, 125:33-43.
3. Bleicher K.H., Bohm H.J., Muller K., Alanine A.I. Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov 2003, 2:369-378.
4. Borden L.A., Caplan M.J. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem Int 1996, 29:335-356.
5. Brindel I., Preud'homme J.L., Diaz J.J., Giraud C., Vallat J.M., Jauberteau M.O. A human monoclonal IgMgamma specific for an epitope shared by the 200kDa neurofilament protein, histones and ribosomal proteins. J Autoimmun 1995, 8:915-929.
6. de Matos L.L., Trufelli D.C., de Matos M.G.L., Pinhal M.A.S. Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomark Insights 2010, 9-20.
7. Dunn J.R., Reed J.E., du Plessis D.G., Shaw E.J., Reeves P., Gee A.L., et al. Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours. Br J Cancer 2006, 94:1186-1193.
8. Fejes Toth K., Knoch T.A., Wachsmuth M., Frank-Stohr M., Stohr M., Bacher C.P., et al. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. J Cell Sci 2004, 117:4277-4287.
9. Futamura M., Monden Y., Okabe T., Fujita-Yoshigaki J., Yokoyama S., Nishimura S. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. Oncogene 1995, 10:1119-1123.
10. Glynn M.W., McAllister A.K. Immunocytochemistry and quantification of protein colocalization in cultured neurons. Nat Protoc 2006, 1:1287-1296.
11. Gorisch S.M., Wachsmuth M., Toth K.F., Lichter P., Rippe K. Histone acetylation increases chromatin accessibility. J Cell Sci 2005, 118:5825-5834.
12. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001, 20:6969-6978.
13. Grimsey N.L., Goodfellow C.E., Scotter E.L., Dowie M.J., Glass M., Graham E.S. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!. J Neurosci Methods 2008, 171:78-86.
14. Hendzel M.J., Kruhlak M.J., Bazett-Jones D.P. Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation. Mol Biol Cell 1998, 9:2491-2507.
15. Henn A.D., Rebhahn J., Brown M.A., Murphy A.J., Coca M.N., Hyrien O., et al. Modulation of single-cell IgG secretion frequency and rates in human memory B cells by CpG DNA, CD40L, IL-21, and cell division. J Immunol 2009, 183:3177-3187.
16. Hoshikawa Y., Kwon H.J., Yoshida M., Horinouchi S., Beppu T. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res 1994, 214:189-197.
17. Huang Y., Zhou X., Miao B., Lipinski M., Zhang Y., Li F., et al. A computational framework for studying neuron morphology from in vitro high content neuron-based screening. J Neurosci Methods 2010, 190:229-309.
18. Kadin M.E. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 1997, 30:77-86.
19. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004, 116:259-272.
20. Klein D., Kern R.M., Sokol R.Z. A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 1995, 36:59-66.
21. Koene R.A., Tijms B., Van Hees P., Postma F., De Ridder A., Ramakers G.J.A., et al. NETMORPH: a framework for the stochastic generation of large scale neuronal networks with realistic neuron morphologies. Neuroinformatics 2009, 7:195-210.
22. Le Beyec J., Xu R., Lee S.Y., Nelson C.M., Rizki A., Alcaraz J., et al. Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp Cell Res 2007, 313:3066-3075.
23. Levsky J.M., Singer R.H. Gene expression and the myth of the average cell. Trends Cell Biol 2003, 13:4-6.
24. Lim J.H., Gibbons H.M., O'Carroll S.J., Narayan P.J., Faull R.L., Dragunow M. Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Res 2007, 1164:1-13.
25. Marks P.A., Richon V.M., Rifkind R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000, 92:1210-1216.
26. Mijac V., Ranin L., Markovic M., Heeg C., Reinert R.R., Opavski N. Distribution of emm types among group A streptococcal isolates from Serbia. Clin Microbiol Infect 2010, 16:295-298.
27. Mohamed M.A., Greif P.A., Diamond J., Sharaf O., Maxwell P., Montironi R., et al. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007, 99:908-915.
28. Musri M.M., Corominola H., Casamitjana R., Gomis R., Parrizas M. Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 2006, 281:17180-17188.
29. Narayan P., Dragunow M. Pharmacology of epigenetics in brain disorders. Br J Pharmacol 2010, 159:285-303.
30. Narayan P.J., Gibbons H.M., Mee E.W., Faull R.L., Dragunow M. High throughput quantification of cells with complex morphology in mixed cultures. J Neurosci Methods 2007, 164:339-349.
31. Padilla-Parra S., Auduge N., Coppey-Moisan M., Tramier M. Quantitative FRET analysis by fast acquisition time domain FLIM at high spatial resolution in living cells. Biophys J 2008, 95:2976-2988.
32. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001, 276:36734-36741.
33. Said H.M., Hagemann C., Stojic J., Schoemig B., Vince G.H., Flentje M., et al. GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol 2007, 8.
34. Saykin A.J., West J., Shen L., Firpi H.A., Wessels A., Cannon A., et al. IC-P2-132: hippocampal and distributed gray matter abnormalities in MCI and early AD in the ADNI baseline 1.5T MRI scans: cross-sectional analysis and relation to verbal learning. Alzheimer's Dementia 2008, 4:T59.
35. Sjoholt G., Anensen N., Wergeland L., Mc Cormack E., Bruserud O., Gjertsen B.T. Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy. Curr Drug Targets 2005, 6:631-646.
36. Skoglund T.S., Pascher R., Berthold C.H. Aspects of the quantitative analysis of neurons in the cerebral cortex. J Neurosci Methods 1996, 70:201-210.
37. Sous F.J., Bash R., Yodh J., Lindsay S.M., Lohr D. A statistical thermodynamic model applied to experimental AFM population and location data is able to quantify DNA-histone binding strength and internucleosomal interaction differences between acetylated and unacetylated nucleosomal arrays. Biophys J 2004, 87:3372-3387.
38. Takahashi I., Miyaji H., Yoshida T., Sato S., Mizukami T. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. J Antibiot (Tokyo) 1996, 49:453-457.
39. Taunton J., Hassig C.A., Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996, 272:408-411.
40. Thiagalingam S., Cheng K.H., Lee H.J., Mineva N., Thiagalingam A., Ponte J.F. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann NY Acad Sci 2003, 983:84-100.
41. Tumbar T., Sudlow G., Belmont A.S. Large-scale chromatin unfolding and remodeling induced by VP16 acidic activation domain. J Cell Biol 1999, 145:1341-1354.
42. Urdinguio R.G., Pino I., Ropero S., Fraga M.F., Esteller M. Histone H3 and H4 modification profiles in a Rett syndrome mouse model. Epigenetics 2007, 2:11-14.
43. Verschure P.J., Van Der Kraan I., Manders E.M.M., Van Driel R. Spatial relationship between transcription sites and chromosome territories. J Cell Biol 1999, 147:13-24.
44. Vigushin D.M., Ali S., Pace P.E., Mirsaidi N., Ito K., Adcock I., et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res 2001, 7:971-976.
45. Waldvogel H.J., Baer K., Snell R.G., During M.J., Faull R.L., Rees M.I. Distribution of gephyrin in the human brain: an immunohistochemical analysis. Neuroscience 2003, 116:145-156.
46. Waldvogel H.J., Bullock J.Y., Synek B.J., Curtis M.A., van Roon-Mom W.M., Faull R.L. The collection and processing of human brain tissue for research. Cell Tissue Bank 2008, 9:169-179.
47. Waldvogel H.J., Curtis M.A., Baer K., Rees M.I., Faull R.L. Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc 2006, 1:2719-2732.
48. Wan M., Zhao K., Lee S.S.J., Francke U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum Mol Genet 2001, 10:1085-1092.